Increased activity of cyclooxygenase-2 (COX-2) has been noted in lung cancer, and PTE has been identified to regulate the growth and apoptosis of NSCLC cells by focusing on COX-2 (Wang et al., 2023). The gene discussed is PTGS2; the disease is lung cancer.